Dihydroartemisinin/Piperaquine for the treatment of uncomplicated P. falciparum malaria

M. Corsi
Dihydroartemisinin/Piperaquine is a fixed-dose Artemisinin-based Combination Therapy (ACT) which contains dihydroartemisinin (DHA), a derivative of artemisinin, and piperaquine (PQP). It has been developed for the treatment of uncomplicated Plasmodium falciparum malaria. The registration Dossier[for full text, please go to the a.m. URL]